首页> 外文期刊>Cardiovascular revascularization medicine: including molecular interventions >Same versus next day discharge after elective transradial PCI: The RAdial SAme Day DischArge after PCI trial. (The RASADDA-PCI trial)
【24h】

Same versus next day discharge after elective transradial PCI: The RAdial SAme Day DischArge after PCI trial. (The RASADDA-PCI trial)

机译:相同的与第二天放电选修巨大PCI:PCI试验后的径向当天放电。 (Rasadda-PCI试验)

获取原文
获取原文并翻译 | 示例
           

摘要

Background and purposeTransradial percutaneous coronary intervention (TR-PCI) has been increasingly popular over the last decade in the US. Previous studies have shown that same-day (SD) discharge after elective PCI is as safe as overnight (ON) observation. Our study was performed to assess the clinical and financial impact of early discharge in patients undergoing TR-PCI. MethodsThis is a single center registry of patients undergoing elective TR-PCI. Timing of discharge was determined by the treating physician. (Groups: Same Day Discharge –SD-; Overnight Stay –ON-). Demographic data, procedural characteristics and adverse outcomes were recorded. Outcomes included 30?day-MACE and procedure- related complications, as well as total operative costs in patients from both groups. Propensity score matching for patient demographics, coronary symptoms and procedure indicators was used to compare both groups. ResultsThe entire cohort included 852 patients (429 in SD group and 423 in ON group) and the propensity score matched groups of 245 patients in the SD group and 245 patients in the ON group. The two groups had no significant baseline clinical differences, and had similar clinical outcomes. Specifically, no significant difference was noted in procedural complications (3.7% vs 2.5%, p?=?0.43), re-hospitalization (4.1% vs 4.1%, p?=?0.92), re-intervention (2.5% vs 2.1%, p?=?0.77), myocardial infarction (0% vs 0.08%, p?=?0.15), stroke (0% vs 0%, p?=?1.0) and all-cause mortality (0% vs 0%, p?=?1.0). SD Group patients had a significant lower procedure-related cost compared to overnight stay patients ($3,346.45 vs $4,681.99, p?
机译:背景和Perposetransradial经皮冠状动脉干预(TR-PCI)在美国过去十年中越来越受欢迎。以前的研究表明,选择PCI后的当天(SD)放电与过夜一样安全(开启)观察。我们的研究进行了评估早期放电对TR-PCI患者的临床和财务影响。方法是接受选修TR-PCI的患者的单一中心注册表。排放时间由治疗医师确定。 (组:当天排放 - ;一夜之间停留 - on-)。记录了人口统计数据,程序特征和不利结果。结果包括30个?阶段和程序相关的并发症,以及两组患者的总操作成本。用于患者人口统计学,冠状动脉症状和程序指标的倾向得分匹配来比较这两个群体。结果队员包括852名患者(429名SD组和423次),SD组245名患者的倾向评分群体匹配群体和245名患者。两组没有显着的基线临床差异,并具有类似的临床结果。具体而言,在程序并发症中没有发现显着差异(3.7%Vs 2.5%,P?= 0.43),重新住院(4.1%Vs 4.1%,P?= 0.92),重新干预(2.5%Vs 2.1% ,p?= 0.77),心肌梗死(0%vs 0.08%,p?=Δ0.15),中风(0%vs 0%,p?=?1.0)和全导致死亡率(0%vs 0%, p?=?1.0)。与过夜住宿患者相比,SD组患者的程序与较低的程序相关成本(3,346.45美元,P?<?0.0001)和低30天的30天后期相关累计成本/总运营成本($ 4,493.22 VS $ 7,112.21,P?< ?0.0001)。结论在低风险TR-PCI的选修患者中,当天排放似乎是一种安全可行的临床实践,对美国医疗保健系统具有显着潜在的潜在节约。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号